Exploratory Study on Artifact Denoising of Cerebral Blood Flow and EEG Data in Ambulance Settings
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Participants are not assigned to interventions based on a protocol..
- Who it may be relevant to
- Registry conditions: Normal, EEG, FNIRS. Basic parameters: 19 years — 80 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The purpose is to assess the extent of digital noise occurring during the measurement of cerebral blood flow and EEG in healthy adults within an ambulance setting and to explore the possibility of identifying and correcting abnormal patterns.
Interventions
- Other Participants are not assigned to interventions based on a protocol.
Participants are not assigned to interventions based on a protocol.
Primary outcome measures
- Electroencephalography (EEG) signals in the ambulance [Time frame: 10 minutes by boarding an ambulance in driving]
Secondary outcome measures (1)
- Functional Near-Infrared Spectroscopy(fNIRS) signals in the ambulance [Time frame: 10 minutes by boarding an ambulance in driving]
Eligibility criteria
Inclusion criteria
- Healthy adults aged 19 to 80 years.
- Individuals without chronic diseases (e.g., Stage 2 hypertension, cardiovascular disease, chronic kidney disease, chronic pulmonary disease, etc.).
- Individuals without mental health disorders (e.g., depression, schizophrenia, etc.).
- Individuals not taking medications that could affect cerebral hemodynamics, such as antihypertensives, anticoagulants, antiplatelets, antidepressants, etc.
Individuals who can read and understand the participant information and consent form and have sufficient language ability to respond to questionnaires.
\- Individuals who voluntarily decide to participate in the clinical study, provide written consent on the participant consent form, and are able to participate throughout the entire duration of the clinical study.
Exclusion criteria
- Individuals who have experienced head trauma in the past 6 months.
- Individuals with ongoing severe chronic diseases (e.g., heart failure, chronic kidney disease, chronic pulmonary disease, etc.).
- Individuals with severe mental health disorders such as schizophrenia, severe depression, bipolar disorder, etc.
- Individuals currently taking medications that may affect the study (e.g., antihypertensives, anticoagulants, antiplatelets, antidepressants, etc.).
- Individuals who have participated in a clinical trial and taken experimental drugs within the past 30 days.
- Women who are pregnant or breastfeeding.
- Individuals who have undergone major surgery in the past 6 months.
- Individuals with acute infections or inflammatory diseases.
- Individuals with cognitive impairment or dementia.
- Individuals with neurological disorders.
- Individuals who lack understanding of the study procedures or who have not voluntarily consented to participate.
- Individuals with clinically significant findings that the study principal investigator or responsible medical personnel determines to be inappropriate for participation in this study.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Case-crossover
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT06701708 · 11-2024-058